Related Experiment Video
Updated: Aug 21, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms
Takemi Akahane1, Manabu Akahane, Amy Shah
1Laboratory of Cellular Carcinogenesis and Tumor Promotion, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4255, USA.
Abstract:
It was reported over a decade ago that tissue inhibitor of metalloproteinases-1 (TIMP-1) suppresses angiogenesis in experimental models but the mechanism is still incompletely understood. This in vitro study focused on the molecular basis of TIMP-1-mediated inhibition of endothelial cell (EC) migration, a key step in the angiogenic process. Both recombinant human TIMP-1 and the synthetic MMP inhibitors, GM6001 and MMP-2-MMP-9 Inhibitor III, suppressed migration of human dermal microvascular endothelial cells (HDMVEC) in a dose-dependent fashion. The MMP-dependent inhibition of migration was associated with increased expression of the junctional adhesion proteins, VE-cadherin and PECAM-1, and VE-cadherin accumulation at cell-cell junctions. TIMP-1 also caused MMP-independent dephosphorylation of focal adhesion kinase (FAK) (pY397) and paxillin, which was associated with reduced number of F-actin stress fibers and focal adhesions. Moreover, TIMP-1 stimulated expression of PTEN that has been shown to reduce phosphorylation of FAK and inhibit cell migration. Our data suggest that TIMP-1 inhibits HDMVEC migration through MMP-dependent stimulation of VE-cadherin and MMP-independent stimulation of PTEN with subsequent dephosphorylation of FAK and cytoskeletal remodeling.
Insights
Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits endothelial cell migration by increasing cell-cell adhesion proteins and decreasing focal adhesion kinase signaling. This clarifies TIMP-1
Area of Science:
- Molecular Biology
- Cell Biology
- Angiogenesis Research
Background:
- Tissue inhibitor of metalloproteinases-1 (TIMP-1) is known to suppress angiogenesis.
- The precise molecular mechanisms underlying TIMP-1's anti-angiogenic effects remain incompletely understood.
- Endothelial cell (EC) migration is a critical process in angiogenesis.
Purpose of the Study:
- To elucidate the molecular mechanisms by which TIMP-1 inhibits endothelial cell migration.
- To investigate the roles of matrix metalloproteinases (MMPs) and focal adhesion kinase (FAK) signaling in TIMP-1's effects.
Main Methods:
- In vitro study using human dermal microvascular endothelial cells (HDMVEC).
- Treatment with recombinant human TIMP-1 and synthetic MMP inhibitors (GM6001, MMP-2-MMP-9 Inhibitor III).
- Analysis of endothelial cell migration, expression of junctional adhesion proteins (VE-cadherin, PECAM-1), FAK phosphorylation, PTEN expression, and cytoskeletal organization.
Main Results:
- TIMP-1 and MMP inhibitors dose-dependently suppressed HDMVEC migration.
- MMP-dependent inhibition involved increased VE-cadherin and PECAM-1 expression and VE-cadherin accumulation at cell junctions.
- MMP-independent inhibition involved FAK and paxillin dephosphorylation, reduced F-actin stress fibers, and stimulated PTEN expression.
Conclusions:
- TIMP-1 inhibits endothelial cell migration via a dual mechanism.
- MMP-dependent pathway: enhanced VE-cadherin expression and cell-cell adhesion.
- MMP-independent pathway: PTEN stimulation, FAK dephosphorylation, and cytoskeletal remodeling.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Role of Matrix Metalloproteases in Degradation of ECM
A...
Mechanism of Angiogenesis
Intracellular Signaling Affects Focal Adhesions
Some...
The Tumor Microenvironment
Overview of Cell-Matrix Interactions

